Medicare’s first round of drug price negotiation - measuring success

New England Journal of Medicine

16 October 2024 - The Federal Government has proven that it can navigate the difficult process of identifying drugs for price negotiation, gathering and analysing key information, and negotiating with manufacturers.

Read New England Journal of Medicine Perspective

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Medicare , Pricing